Literature DB >> 9827354

Influence of the anti-allergic agent, azelastine, on tumor necrosis factor-alpha (TNF-alpha) secretion from cultured mouse mast cells.

S Matsuo1, S Takayama.   

Abstract

The influence of azelastine (AZ) on tumor necrosis factor-alpha (TNF-alpha) secretllon from cultured mast cells was examined. Mast cells were induced by the long-term culture of mouse (BALB/c, Male) spleen cells with interleukin-3. Mast cells collected on day 20 in culture were stimulated with 2.5 micrograms/ml of concanavalin A (Con A) in the presence of various doses of AZ for 24 hours. AZ scarcely affected TNF-alpha secretion from mast cells when low doses (0.5 and 1.0 microgram/ml) of AZ were added to cultures. However, higher doses (5.0 and 10.0 micrograms/ml) of AZ inhibited the secretion (but not production) of TNF-alpha from mast cells. These results may suggest that some of the therapeutic effects of AZ depend on its ability to reduce the secretion of TNF-alpha from mast cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827354

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  The Nose as a Route for Therapy: Part 1. Pharmacotherapy.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Dimitrios I Mitsias; Nikolaos G Papadopoulos; Ludger Klimek; Anu Laulajainen-Hongisto; Maija Hytönen; Sanna Katriina Toppila-Salmi; Glenis Kathleen Scadding
Journal:  Front Allergy       Date:  2021-02-22

3.  Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.

Authors:  Friedrich Horak
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.